图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
环境病理学,毒理学和肿瘤学期刊
影响因子: 1.241 5年影响因子: 1.349 SJR: 0.519 SNIP: 0.613 CiteScore™: 1.61

ISSN 打印: 0731-8898
ISSN 在线: 2162-6537

环境病理学,毒理学和肿瘤学期刊

DOI: 10.1615/JEnvironPatholToxicolOncol.2018025265
pages 27-41

Partially Purified Aqueous Fraction of Desmodium gyrans DC Improves Reverse Cholesterol Transport and Lipoprotein Metabolism in Wistar Rats Fed with High Fat Diet

M. S. Indu
Department of Biochemistry, Amala Cancer Research Centre, Thrissur
Jose Padikkala
Department of Biochemistry, Amala Cancer Research Centre, Thrissur
Achuthan C. Raghavamenon
Department of Biochemistry, Amala Cancer Research Centre, Thrissur

ABSTRACT

Apart from the conventional hypolipidemic therapy, plaque regression through enhanced reverse cholesterol transport (RCT) has emerged as novel approach in atherosclerotic drug development. High-density lipoprotein (HDL) mimetics as well as agents that augment the functional HDL and RCT pathways are under intense exploration. Desmodium gyrans (Fabacea) has been shown to have hypolipidemic efficacy, with an HDL-enhancing property. In this study, a chromatographically purified active fraction of D. gyrans (DGMAF) significantly decreased the serum and lipid profiles as well as lipotoxicity in liver in Wistar rats fed with high-fat diet (HFD). Except for the marginal deposition of liver lipids, all other organs showed no weight gain due to lipid accumulation. A lower level of lipid peroxidation and a reduced atherogenic index suggests the hypolipidemic efficacy of DGMAF, which was comparatively higher than clinically used atorvastatin. Furthermore, the DGMAF-treated animals had enhanced levels of HDL, associated ApoA-1, and paraoxonase activity. The mRNA levels of ApoA-1 and SR-B1 were upregulated, and cholesteryl ester transfer protein (CETP) was downregulated. Overall, the results of this study indicate that D. gyrans augments the RCT pathway and improves the lipid metabolism in rats fed an HFD.

键词: DGMAF, HDL, RCT, SR-BI, ApoA-1, CETP

Articles with similar content:

Effects of Concurrently Administered Aqueous Extract of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Lead Acetate in Rats
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 2
Michael T. Sobowale, Raymond I. Ozolua, Buniyamin A. Ayinde, Dickson O. Uwaya
Development of an Anti-Atherosclerotic Polyherbal Formulation: GSTC3
Journal of Environmental Pathology, Toxicology and Oncology, Vol.34, 2015, issue 3
Merin Baby, Smitha K. Ramavarma, Achuthan C. Raghavamenon, Jeksy J. Manalil, Jose Padikkala, Indu M. Suseela
Antimutagenic Activity of Methanolic Extract of Culinary-Medicinal Oyster mushroom, Pleurotus ostreatus (Jacq.:Fr.) Kumm. (strain florida Eger nom. nud.) and Its Protective Effect Against Benzo [a] Pyrene-Induced Hepatic Damages
International Journal of Medicinal Mushrooms, Vol.6, 2004, issue 2
Thekkuttuparambil Ananthanarayanan Ajith, Kainoor K. Janardhanan, Nayana Jose, Bhaskaran Lakshmi
Nephroprotective Effect of Bauhinia tomentosa Linn against Cisplatin-Induced Renal Damage
Journal of Environmental Pathology, Toxicology and Oncology, Vol.35, 2016, issue 2
Chandrasekaran Guruvayoorappan, Kunnathur Murugesan Sakthivel , Narayanan Kannan
Hepato- and Nephroprotective Activities of a Nigerian Local King Tuber Oyster Mushroom, Pleurotus tuberregium (Higher Basidiomycetes), in Chemically Induced Organ Toxicities in Rats
International Journal of Medicinal Mushrooms, Vol.16, 2014, issue 4
Stella A. Ihim, Kolawole A. Laiyemo, Chukwuemeka Sylvester Nworu, Peter A. Akah, Loveth E. Ugwu